Certain cancers like mucin-secreting gastric and pancreatic adenocarcinomas are believed to place patients at the highest increased risk for VTE, but recent studies have found that GI neuroendocrine tumors also have been associated with an increased VTE risk, albeit not as severe as seen with their adenocarcinoma counterparts [14]. Here, MUC5AC is linked to adenocarcinoma.